Period Ending | Jun 29, 2012 | Mar 30, 2012 | Dec 30, 2011 | Sep 29, 2011 |
---|
Total Revenue
|
2,405,186
|
2,282,449
|
2,200,378
|
2,121,660
| Cost of Revenue | 617,345 | 580,931 | 584,447 | 531,989 | |
Gross Profit
|
1,787,841
|
1,701,518
|
1,615,931
|
1,589,671
| |
|
Operating Expenses |
|
Research Development | 396,244 | 458,211 | 402,236 | 290,066 |
|
Selling General and Administrative | 332,505 | 443,121 | 346,219 | 295,927 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | |
Operating Income or Loss
|
1,059,092
|
800,186
|
867,476
|
1,003,678
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (1,075) | (34,085) | 26,365 | 14,406 |
|
Earnings Before Interest And Taxes | 1,058,017 | 766,101 | 893,841 | 1,018,084 |
|
Interest Expense | 88,418 | 97,270 | 74,998 | 43,097 |
|
Income Before Tax | 969,599 | 668,831 | 818,843 | 974,987 |
|
Income Tax Expense | 263,525 | 231,300 | 157,084 | 237,449 |
|
Minority Interest | 5,490 | 4,425 | 3,386 | 3,586 |
|
|
|
Net Income From Continuing Ops | 711,564 | 441,956 | 665,145 | 741,124 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | |
Net Income
|
711,564
|
441,956
|
665,145
|
741,124
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
711,564
|
441,956
|
665,145
|
741,124
|
|